FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称LEXATUMUMAB
异名/同义词ETR2-ST01
HGS1018
HGS-1018
HGS-ETR2
IMMUNOGLOBULIN G1, ANTI-(HUMAN CYTOKINE RECEPTOR TRAIL-R2) (HUMAN MONOCLONAL HGS-ETR2 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL HGS-ETR2 .LAMBDA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN CYTOKINE RECEPTOR TRAIL-R2) (HUMAN MONOCLONAL HGS-ETR2 HEAVY CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL HGS-ETR2 .LAMBDA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 10B (DEATH RECEPTOR 5 OR TRAIL-R2)) (HUMAN MONOCLONAL HGS-ETR2 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL HGS-ETR2 .LAMBDA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 10B (DEATH RECEPTOR 5 OR TRAIL-R2)) (HUMAN MONOCLONAL HGS-ETR2 HEAVY CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL HGS-ETR2 .LAMBDA.-CHAIN, DIMER
LEXATUMUMAB
LEXATUMUMAB [INN]
LEXATUMUMAB [USAN]
LEXATUMUMAB [WHO-DD]
CAS登记号845816-02-6
物质唯一标识(Unique Ingredient Identifier)967Q0SJD77
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System